Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 595,100 | 592,000 | 566,800 | 534,400 | 512,600 |
| Cost of Goods | 505,800 | 502,400 | 478,900 | 450,700 | 434,100 |
| Gross Profit | 89,300 | 89,600 | 87,900 | 83,700 | 78,500 |
| Operating Expenses | 79,900 | 78,400 | 79,600 | 73,400 | 66,600 |
| Operating Income | 10,200 | 11,600 | 9,200 | 11,000 | 12,000 |
| Interest Expense | 4,100 | 4,100 | 3,700 | 200 | 3,000 |
| Pre-tax Income | 6,100 | 7,500 | 5,500 | 10,800 | 9,000 |
| Income Tax | 2,900 | 2,800 | 2,000 | 3,100 | 1,700 |
| Net Income Continuous | 3,200 | 4,700 | 3,500 | 7,700 | 7,300 |
| Net Income | $3,200 | $4,700 | $3,500 | $7,700 | $7,300 |
| EPS Basic Total Ops | 0.10 | 0.15 | 0.11 | 0.25 | 0.24 |
| EPS Basic Continuous Ops | 0.10 | 0.15 | 0.11 | 0.25 | 0.24 |
| EPS Diluted Total Ops | 0.10 | 0.15 | 0.11 | 0.25 | 0.23 |
| EPS Diluted Continuous Ops | 0.10 | 0.15 | 0.11 | 0.25 | 0.24 |
| EPS Diluted Before Non-Recurring Items | 0.46 | 0.47 | 0.42 | 0.58 | 0.44 |
| EBITDA(a) | $27,000 | $28,500 | $25,400 | $26,800 | $26,600 |